Office of the Director, National Institutes of Health; Notice of Meeting, 62081 [2011-25865]
Download as PDF
<![CDATA[
Federal Register / Vol. 76, No. 194 / Thursday, October 6, 2011 / Notices
Research Support; 93.821, Cell Biology and
Biophysics Research; 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.862, Genetics and
Developmental Biology Research; 93.88,
Minority Access to Research Careers; 93.96,
Special Minority Initiatives, National
Institutes of Health, HHS)
Dated: September 29, 2011.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2011–25866 Filed 10–5–11; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Office of the Director, National
Institutes of Health; Notice of Meeting
mstockstill on DSK4VPTVN1PROD with NOTICES
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
Scientific Management Review Board.
The NIH Reform Act of 2006 (Pub. L.
109–482) provides organizational
authorities to HHS and NIH officials to:
(1) Establish or abolish national research
institutes; (2) reorganize the offices
within the Office of the Director, NIH
including adding, removing, or
transferring the functions of such offices
or establishing or terminating such
offices; and (3) reorganize, divisions,
centers, or other administrative units
within an NIH national research
institute or national center including
adding, removing, or transferring the
functions of such units, or establishing
or terminating such units. The purpose
of the Scientific Management Review
Board (also referred to as SMRB or
Board) is to advise appropriate HHS and
NIH officials on the use of these
organizational authorities and identify
the reasons underlying the
recommendations.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Name of Committee: Scientific
Management Review Board.
Date: October 26, 2011.
Time: 9 a.m. to 5 p.m.
Agenda: Presentation and discussion will
focus on NIH activities related to SMRB
recommendations issued in its Report on
Translational Medicine and Therapeutics;
Report on the NIH Clinical Center; and
Report on Substance Use, Abuse, and
VerDate Mar<15>2010
16:07 Oct 05, 2011
Jkt 226001
Addiction Research at NIH. The Board will
also discuss future SMRB activities. Further
information for this meeting, including the
agenda, will be available at https://
smrb.od.nih.gov. Time will be allotted on the
agenda for public comment. To sign up for
public comments electronically, please send
an email with your name and affiliation to
the Contact Person’s e-mail address listed
below by October 25, 2011. Sign up for
public comments in person will begin
approximately at 8:30 a.m. on October 26,
2011. Sign-up participants’ comments will be
restricted to one person per sign in. In the
event that time does not allow for all those
interested to present oral comments, anyone
may file written comments using the Contact
Person’s address below.
Place: National Institutes of Health,
Building 31, 6th Floor, Conference Room 6,
31 Center Drive, Bethesda, MD 20892.
Contact Person: Lyric Jorgenson, PhD,
Office of Biotechnology Activities, Office of
Science Policy, Office of the Director, NIH,
National Institutes of Health, 6705 Rockledge
Drive, Suite 750, Bethesda, MD 20892,
smrb@mail.nih.gov, (301) 496–6837.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
The meeting will also be webcast. The draft
meeting agenda, meeting materials, dial-in
information, and other information about the
SMRB, will be available at https://
smrb.od.nih.gov.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitors vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.14, Intramural Research
Training Award; 93.22, Clinical Research
Loan Repayment Program for Individuals
from Disadvantaged Backgrounds; 93.232,
Loan Repayment Program for Research
Generally; 93.39, Academic Research
Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan
Repayment Program; 93.187, Undergraduate
Scholarship Program for Individuals from
Disadvantaged Backgrounds, National
Institutes of Health, HHS)
Dated: September 30, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2011–25865 Filed 10–5–11; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00047
Fmt 4703
Sfmt 4703
62081
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Vascular and
Hematology Integrated Review Group,
Atherosclerosis and Inflammation of the
Cardiovascular System Study.
Date: October 17–18, 2011.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Anshumali Chaudhari,
PhD, Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4124,
MSC 7802, Bethesda, MD 20892, (301) 435–
1210, chaudhaa@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Vascular
and Hematology AREA Proposals.
Date: October 25–26, 2011.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Ai-Ping Zou, M.D., PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4118,
MSC 7814, Bethesda, MD 20892, 301–435–
1777, zouai@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel,
Bioengineering Sciences and Technologies
R15 Panel 1: Area Proposals.
Date: October 26–27, 2011.
Time: 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Raymond Jacobson, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5858,
E:\FR\FM\06OCN1.SGM
06OCN1
]]>Agencies
[Federal Register Volume 76, Number 194 (Thursday, October 6, 2011)]
[Notices]
[Page 62081]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-25865]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Office of the Director, National Institutes of Health; Notice of
Meeting
Pursuant to section 10(a) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of a meeting of the
Scientific Management Review Board.
The NIH Reform Act of 2006 (Pub. L. 109-482) provides
organizational authorities to HHS and NIH officials to: (1) Establish
or abolish national research institutes; (2) reorganize the offices
within the Office of the Director, NIH including adding, removing, or
transferring the functions of such offices or establishing or
terminating such offices; and (3) reorganize, divisions, centers, or
other administrative units within an NIH national research institute or
national center including adding, removing, or transferring the
functions of such units, or establishing or terminating such units. The
purpose of the Scientific Management Review Board (also referred to as
SMRB or Board) is to advise appropriate HHS and NIH officials on the
use of these organizational authorities and identify the reasons
underlying the recommendations.
The meeting will be open to the public, with attendance limited to
space available. Individuals who plan to attend and need special
assistance, such as sign language interpretation or other reasonable
accommodations, should notify the Contact Person listed below in
advance of the meeting.
Name of Committee: Scientific Management Review Board.
Date: October 26, 2011.
Time: 9 a.m. to 5 p.m.
Agenda: Presentation and discussion will focus on NIH activities
related to SMRB recommendations issued in its Report on
Translational Medicine and Therapeutics; Report on the NIH Clinical
Center; and Report on Substance Use, Abuse, and Addiction Research
at NIH. The Board will also discuss future SMRB activities. Further
information for this meeting, including the agenda, will be
available at https://smrb.od.nih.gov. Time will be allotted on the
agenda for public comment. To sign up for public comments
electronically, please send an email with your name and affiliation
to the Contact Person's e-mail address listed below by October 25,
2011. Sign up for public comments in person will begin approximately
at 8:30 a.m. on October 26, 2011. Sign-up participants' comments
will be restricted to one person per sign in. In the event that time
does not allow for all those interested to present oral comments,
anyone may file written comments using the Contact Person's address
below.
Place: National Institutes of Health, Building 31, 6th Floor,
Conference Room 6, 31 Center Drive, Bethesda, MD 20892.
Contact Person: Lyric Jorgenson, PhD, Office of Biotechnology
Activities, Office of Science Policy, Office of the Director, NIH,
National Institutes of Health, 6705 Rockledge Drive, Suite 750,
Bethesda, MD 20892, smrb@mail.nih.gov, (301) 496-6837.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
The meeting will also be webcast. The draft meeting agenda,
meeting materials, dial-in information, and other information about
the SMRB, will be available at https://smrb.od.nih.gov.
In the interest of security, NIH has instituted stringent
procedures for entrance onto the NIH campus. All visitors vehicles,
including taxicabs, hotel, and airport shuttles will be inspected
before being allowed on campus. Visitors will be asked to show one
form of identification (for example, a government-issued photo ID,
driver's license, or passport) and to state the purpose of their
visit.
(Catalogue of Federal Domestic Assistance Program Nos. 93.14,
Intramural Research Training Award; 93.22, Clinical Research Loan
Repayment Program for Individuals from Disadvantaged Backgrounds;
93.232, Loan Repayment Program for Research Generally; 93.39,
Academic Research Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan Repayment Program; 93.187,
Undergraduate Scholarship Program for Individuals from Disadvantaged
Backgrounds, National Institutes of Health, HHS)
Dated: September 30, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2011-25865 Filed 10-5-11; 8:45 am]
BILLING CODE 4140-01-P
